A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity

Documenti analoghi

• Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression level
  di: Song, De-Gang, et al.
  Pubblicazione: (2016)
• Chimeric antigen receptor T cells with dissociated signaling domains exhibit focused anti-tumor activity with reduced potential for toxicity in vivo
  di: Lanitis, Evripidis, et al.
  Pubblicazione: (2013)
• Rigorous optimization and validation of potent RNA CAR T cell therapy for the treatment of common epithelial cancers expressing folate receptor
  di: Schutsky, Keith, et al.
  Pubblicazione: (2015)
• In vivo persistence, tumor localization and anti-tumor activity of CAR engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)
  di: Song, De-Gang, et al.
  Pubblicazione: (2011)
• Redirected Antitumor Activity of Primary Human Lymphocytes Transduced With a Fully Human Anti-mesothelin Chimeric Receptor
  di: Lanitis, Evripidis, et al.
  Pubblicazione: (2012)